DHILLON PUNIT bought SKYE
March 31, 2026 · Form 4 insider transaction
DHILLON PUNIT bought 12,360 shares of Skye Bioscience, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,360
Price
N/A
Total value
N/A
InsiderDHILLON PUNIT
Role—
CompanySkye Bioscience, Inc. (SKYE)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after12,360
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing.; On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged.; The stock option is fully vested.